APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacokinetic Research Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmacokinetic Research Service Market Analysis and Forecast 2026-2032

3 May 2026181 pages

Choose your research edition.

Industry ResearchPharmacokinetic Research Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacokinetic Research Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmacokinetic Research Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacokinetic Research Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacokinetic Research Service Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Pharmacokinetic Research Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmacokinetic Research Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmacokinetic Research Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmacokinetic Research Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmacokinetic Research Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmacokinetic Research Service include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences and Allucent, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmacokinetic Research Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmacokinetic Research Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmacokinetic Research Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmacokinetic Research Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmacokinetic Research Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmacokinetic Research Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmacokinetic Research Service Segment by Company

Eurofins

PPD

LabCorp

Charles River

BioPharma Services

Biotrial

QPS Holdings

Altasciences

Allucent

Admescope

CTI

WuXi AppTec

GenScript

Wuxi Biologics

Medicilon

Pharmaron

Frontage

Shanghai Model

Pharmacokinetic Research Service Segment by Type

In Vitro and Radioactive ADME

In Vivo PK and PD

New Drugs and New Molecules

Other

Pharmacokinetic Research Service Segment by Application

Pharmaceutical Industry

Government and Ministry of Health

Agriculture and Chemical Industry

University

Pharmacokinetic Research Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Research Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Research Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Research Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmacokinetic Research Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmacokinetic Research Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacokinetic Research Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacokinetic Research Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In Vitro and Radioactive ADME Major Player Table 3. In Vivo PK and PD Major Player Table 4. New Drugs and New Molecules Major Player Table 5. Other Major Player Table 6. Global Pharmacokinetic Research Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Industry Major Player Table 8. Government and Ministry of Health Major Player Table 9. Agriculture and Chemical Industry Major Player Table 10. University Major Player Table 11. Pharmacokinetic Research Service Industry Trends Table 12. Pharmacokinetic Research Service Industry Drivers Table 13. Pharmacokinetic Research Service Industry Opportunities and Challenges Table 14. Pharmacokinetic Research Service Industry Restraints Table 15. Global Pharmacokinetic Research Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Pharmacokinetic Research Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Pharmacokinetic Research Service Market Share by Region (2021-2026) Table 18. Global Pharmacokinetic Research Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Pharmacokinetic Research Service Market Share by Region (2027-2032) Table 20. Global Pharmacokinetic Research Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Pharmacokinetic Research Service Revenue Market Share by Players (2021-2026) Table 22. Global Pharmacokinetic Research Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Pharmacokinetic Research Service Key Players Headquarters & Area Served Table 24. Global Pharmacokinetic Research Service Players, Product Type & Application Table 25. Global Pharmacokinetic Research Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Pharmacokinetic Research Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Pharmacokinetic Research Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pharmacokinetic Research Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Pharmacokinetic Research Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Pharmacokinetic Research Service Revenue Market Share by Type (2021-2026) Table 32. Global Pharmacokinetic Research Service Revenue Market Share by Type (2027-2032) Table 33. Global Pharmacokinetic Research Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pharmacokinetic Research Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Pharmacokinetic Research Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Pharmacokinetic Research Service Revenue Market Share by Application (2021-2026) Table 37. Global Pharmacokinetic Research Service Revenue Market Share by Application (2027-2032) Table 38. Eurofins Company Information Table 39. Eurofins Business Overview Table 40. Eurofins Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Eurofins Pharmacokinetic Research Service Product Portfolio Table 42. Eurofins Recent Development Table 43. PPD Company Information Table 44. PPD Business Overview Table 45. PPD Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. PPD Pharmacokinetic Research Service Product Portfolio Table 47. PPD Recent Development Table 48. LabCorp Company Information Table 49. LabCorp Business Overview Table 50. LabCorp Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. LabCorp Pharmacokinetic Research Service Product Portfolio Table 52. LabCorp Recent Development Table 53. Charles River Company Information Table 54. Charles River Business Overview Table 55. Charles River Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Charles River Pharmacokinetic Research Service Product Portfolio Table 57. Charles River Recent Development Table 58. BioPharma Services Company Information Table 59. BioPharma Services Business Overview Table 60. BioPharma Services Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. BioPharma Services Pharmacokinetic Research Service Product Portfolio Table 62. BioPharma Services Recent Development Table 63. Biotrial Company Information Table 64. Biotrial Business Overview Table 65. Biotrial Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Biotrial Pharmacokinetic Research Service Product Portfolio Table 67. Biotrial Recent Development Table 68. QPS Holdings Company Information Table 69. QPS Holdings Business Overview Table 70. QPS Holdings Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. QPS Holdings Pharmacokinetic Research Service Product Portfolio Table 72. QPS Holdings Recent Development Table 73. Altasciences Company Information Table 74. Altasciences Business Overview Table 75. Altasciences Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Altasciences Pharmacokinetic Research Service Product Portfolio Table 77. Altasciences Recent Development Table 78. Allucent Company Information Table 79. Allucent Business Overview Table 80. Allucent Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Allucent Pharmacokinetic Research Service Product Portfolio Table 82. Allucent Recent Development Table 83. Admescope Company Information Table 84. Admescope Business Overview Table 85. Admescope Pharmacokinetic Research Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Admescope Pharmacokinetic Research Service Product Portfolio Table 87. Admescope Recent Development Table 88. CTI Company Information Table 89. CTI Business Overview Table 90. CTI Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. CTI Pharmacokinetic Research Service Product Portfolio Table 92. CTI Recent Development Table 93. WuXi AppTec Company Information Table 94. WuXi AppTec Business Overview Table 95. WuXi AppTec Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. WuXi AppTec Pharmacokinetic Research Service Product Portfolio Table 97. WuXi AppTec Recent Development Table 98. GenScript Company Information Table 99. GenScript Business Overview Table 100. GenScript Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. GenScript Pharmacokinetic Research Service Product Portfolio Table 102. GenScript Recent Development Table 103. Wuxi Biologics Company Information Table 104. Wuxi Biologics Business Overview Table 105. Wuxi Biologics Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Wuxi Biologics Pharmacokinetic Research Service Product Portfolio Table 107. Wuxi Biologics Recent Development Table 108. Medicilon Company Information Table 109. Medicilon Business Overview Table 110. Medicilon Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Medicilon Pharmacokinetic Research Service Product Portfolio Table 112. Medicilon Recent Development Table 113. Pharmaron Company Information Table 114. Pharmaron Business Overview Table 115. Pharmaron Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Pharmaron Pharmacokinetic Research Service Product Portfolio Table 117. Pharmaron Recent Development Table 118. Frontage Company Information Table 119. Frontage Business Overview Table 120. Frontage Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Frontage Pharmacokinetic Research Service Product Portfolio Table 122. Frontage Recent Development Table 123. Shanghai Model Company Information Table 124. Shanghai Model Business Overview Table 125. Shanghai Model Pharmacokinetic Research Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Shanghai Model Pharmacokinetic Research Service Product Portfolio Table 127. Shanghai Model Recent Development Table 128. North America Pharmacokinetic Research Service Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Pharmacokinetic Research Service Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Pharmacokinetic Research Service Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Pharmacokinetic Research Service Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Pharmacokinetic Research Service Revenue by Country (2021-2026) & (US$ Million) Table 134. North America Pharmacokinetic Research Service Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe Pharmacokinetic Research Service Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Pharmacokinetic Research Service Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Pharmacokinetic Research Service Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Pharmacokinetic Research Service Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Pharmacokinetic Research Service Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Pharmacokinetic Research Service Revenue by Country (US$ Million) & (2027-2032) Table 142. China Pharmacokinetic Research Service Revenue by Type (2021-2026) & (US$ Million) Table 143. China Pharmacokinetic Research Service Revenue by Type (2027-2032) & (US$ Million) Table 144. China Pharmacokinetic Research Service Revenue by Application (2021-2026) & (US$ Million) Table 145. China Pharmacokinetic Research Service Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Pharmacokinetic Research Service Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Pharmacokinetic Research Service Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Pharmacokinetic Research Service Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Pharmacokinetic Research Service Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Pharmacokinetic Research Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Pharmacokinetic Research Service Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia Pharmacokinetic Research Service Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA Pharmacokinetic Research Service Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Pharmacokinetic Research Service Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Pharmacokinetic Research Service Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA Pharmacokinetic Research Service Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA Pharmacokinetic Research Service Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA Pharmacokinetic Research Service Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Pharmacokinetic Research Service Image Figure 2. Global Pharmacokinetic Research Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacokinetic Research Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. In Vitro and Radioactive ADME Image Figure 5. In Vivo PK and PD Image Figure 6. New Drugs and New Molecules Image Figure 7. Other Image Figure 8. Global Pharmacokinetic Research Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmacokinetic Research Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Industry Image Figure 11. Government and Ministry of Health Image Figure 12. Agriculture and Chemical Industry Image Figure 13. University Image Figure 14. Global Pharmacokinetic Research Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Pharmacokinetic Research Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Pharmacokinetic Research Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Pharmacokinetic Research Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pharmacokinetic Research Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmacokinetic Research Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pharmacokinetic Research Service Revenue Market Share by Type (2021-2032) Figure 22. Global Pharmacokinetic Research Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmacokinetic Research Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Pharmacokinetic Research Service Revenue Market Share by Application (2021-2032) Figure 25. North America Pharmacokinetic Research Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Pharmacokinetic Research Service Revenue Share by Type (2021-2032) Figure 27. North America Pharmacokinetic Research Service Revenue Share by Application (2021-2032) Figure 28. North America Pharmacokinetic Research Service Revenue Share by Country (2021-2032) Figure 29. United States Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Pharmacokinetic Research Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Pharmacokinetic Research Service Revenue Share by Type (2021-2032) Figure 34. Europe Pharmacokinetic Research Service Revenue Share by Application (2021-2032) Figure 35. Europe Pharmacokinetic Research Service Revenue Share by Country (2021-2032) Figure 36. Germany Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Pharmacokinetic Research Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Pharmacokinetic Research Service Revenue Share by Type (2021-2032) Figure 46. China Pharmacokinetic Research Service Revenue Share by Application (2021-2032) Figure 47. Asia Pharmacokinetic Research Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Pharmacokinetic Research Service Revenue Share by Type (2021-2032) Figure 49. Asia Pharmacokinetic Research Service Revenue Share by Application (2021-2032) Figure 50. Asia Pharmacokinetic Research Service Revenue Share by Region (2021-2032) Figure 51. Japan Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Pharmacokinetic Research Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Pharmacokinetic Research Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Pharmacokinetic Research Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Pharmacokinetic Research Service Revenue Share by Country (2021-2032) Figure 61. Brazil Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Pharmacokinetic Research Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro and Radioactive ADME
  • In Vivo PK and PD
  • New Drugs and New Molecules
  • Other
Applications
  • Pharmaceutical Industry
  • Government and Ministry of Health
  • Agriculture and Chemical Industry
  • University
Companies covered
  • Eurofins
  • PPD
  • LabCorp
  • Charles River
  • BioPharma Services
  • Biotrial
  • QPS Holdings
  • Altasciences
  • Allucent
  • Admescope
  • CTI
  • WuXi AppTec
  • GenScript
  • Wuxi Biologics
  • Medicilon
  • Pharmaron
  • Frontage
  • Shanghai Model

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmacokinetic Research Service Market by Type
  3. 1.2.1 Global Pharmacokinetic Research Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro and Radioactive ADME
  5. 1.2.3 In Vivo PK and PD
  6. 1.2.4 New Drugs and New Molecules
  7. 1.2.5 Other
  8. 1.3 Pharmacokinetic Research Service Market by Application
  9. 1.3.1 Global Pharmacokinetic Research Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Industry
  11. 1.3.3 Government and Ministry of Health
  12. 1.3.4 Agriculture and Chemical Industry
  13. 1.3.5 University
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Pharmacokinetic Research Service Market Dynamics
  1. 2.1 Pharmacokinetic Research Service Industry Trends
  2. 2.2 Pharmacokinetic Research Service Industry Drivers
  3. 2.3 Pharmacokinetic Research Service Industry Opportunities and Challenges
  4. 2.4 Pharmacokinetic Research Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmacokinetic Research Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmacokinetic Research Service Growth Trends by Region
  3. 3.2.1 Global Pharmacokinetic Research Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmacokinetic Research Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmacokinetic Research Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmacokinetic Research Service Revenue by Players
  2. 4.1.1 Global Pharmacokinetic Research Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmacokinetic Research Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmacokinetic Research Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmacokinetic Research Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmacokinetic Research Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmacokinetic Research Service Players, Product Type & Application
  8. 4.5 Global Pharmacokinetic Research Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmacokinetic Research Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmacokinetic Research Service Tier 1, Tier 2, and Tier 3
5 Pharmacokinetic Research Service Market Size by Type
  1. 5.1 Global Pharmacokinetic Research Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacokinetic Research Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmacokinetic Research Service Revenue Market Share by Type (2021-2032)
6 Pharmacokinetic Research Service Market Size by Application
  1. 6.1 Global Pharmacokinetic Research Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmacokinetic Research Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmacokinetic Research Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins
  2. 7.1.1 Eurofins Company Information
  3. 7.1.2 Eurofins Business Overview
  4. 7.1.3 Eurofins Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Pharmacokinetic Research Service Product Portfolio
  6. 7.1.5 Eurofins Recent Developments
  7. 7.2 PPD
  8. 7.2.1 PPD Company Information
  9. 7.2.2 PPD Business Overview
  10. 7.2.3 PPD Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 PPD Pharmacokinetic Research Service Product Portfolio
  12. 7.2.5 PPD Recent Developments
  13. 7.3 LabCorp
  14. 7.3.1 LabCorp Company Information
  15. 7.3.2 LabCorp Business Overview
  16. 7.3.3 LabCorp Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 LabCorp Pharmacokinetic Research Service Product Portfolio
  18. 7.3.5 LabCorp Recent Developments
  19. 7.4 Charles River
  20. 7.4.1 Charles River Company Information
  21. 7.4.2 Charles River Business Overview
  22. 7.4.3 Charles River Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Pharmacokinetic Research Service Product Portfolio
  24. 7.4.5 Charles River Recent Developments
  25. 7.5 BioPharma Services
  26. 7.5.1 BioPharma Services Company Information
  27. 7.5.2 BioPharma Services Business Overview
  28. 7.5.3 BioPharma Services Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BioPharma Services Pharmacokinetic Research Service Product Portfolio
  30. 7.5.5 BioPharma Services Recent Developments
  31. 7.6 Biotrial
  32. 7.6.1 Biotrial Company Information
  33. 7.6.2 Biotrial Business Overview
  34. 7.6.3 Biotrial Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biotrial Pharmacokinetic Research Service Product Portfolio
  36. 7.6.5 Biotrial Recent Developments
  37. 7.7 QPS Holdings
  38. 7.7.1 QPS Holdings Company Information
  39. 7.7.2 QPS Holdings Business Overview
  40. 7.7.3 QPS Holdings Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QPS Holdings Pharmacokinetic Research Service Product Portfolio
  42. 7.7.5 QPS Holdings Recent Developments
  43. 7.8 Altasciences
  44. 7.8.1 Altasciences Company Information
  45. 7.8.2 Altasciences Business Overview
  46. 7.8.3 Altasciences Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Altasciences Pharmacokinetic Research Service Product Portfolio
  48. 7.8.5 Altasciences Recent Developments
  49. 7.9 Allucent
  50. 7.9.1 Allucent Company Information
  51. 7.9.2 Allucent Business Overview
  52. 7.9.3 Allucent Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Allucent Pharmacokinetic Research Service Product Portfolio
  54. 7.9.5 Allucent Recent Developments
  55. 7.10 Admescope
  56. 7.10.1 Admescope Company Information
  57. 7.10.2 Admescope Business Overview
  58. 7.10.3 Admescope Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Admescope Pharmacokinetic Research Service Product Portfolio
  60. 7.10.5 Admescope Recent Developments
  61. 7.11 CTI
  62. 7.11.1 CTI Company Information
  63. 7.11.2 CTI Business Overview
  64. 7.11.3 CTI Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CTI Pharmacokinetic Research Service Product Portfolio
  66. 7.11.5 CTI Recent Developments
  67. 7.12 WuXi AppTec
  68. 7.12.1 WuXi AppTec Company Information
  69. 7.12.2 WuXi AppTec Business Overview
  70. 7.12.3 WuXi AppTec Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 WuXi AppTec Pharmacokinetic Research Service Product Portfolio
  72. 7.12.5 WuXi AppTec Recent Developments
  73. 7.13 GenScript
  74. 7.13.1 GenScript Company Information
  75. 7.13.2 GenScript Business Overview
  76. 7.13.3 GenScript Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GenScript Pharmacokinetic Research Service Product Portfolio
  78. 7.13.5 GenScript Recent Developments
  79. 7.14 Wuxi Biologics
  80. 7.14.1 Wuxi Biologics Company Information
  81. 7.14.2 Wuxi Biologics Business Overview
  82. 7.14.3 Wuxi Biologics Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Wuxi Biologics Pharmacokinetic Research Service Product Portfolio
  84. 7.14.5 Wuxi Biologics Recent Developments
  85. 7.15 Medicilon
  86. 7.15.1 Medicilon Company Information
  87. 7.15.2 Medicilon Business Overview
  88. 7.15.3 Medicilon Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Medicilon Pharmacokinetic Research Service Product Portfolio
  90. 7.15.5 Medicilon Recent Developments
  91. 7.16 Pharmaron
  92. 7.16.1 Pharmaron Company Information
  93. 7.16.2 Pharmaron Business Overview
  94. 7.16.3 Pharmaron Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Pharmaron Pharmacokinetic Research Service Product Portfolio
  96. 7.16.5 Pharmaron Recent Developments
  97. 7.17 Frontage
  98. 7.17.1 Frontage Company Information
  99. 7.17.2 Frontage Business Overview
  100. 7.17.3 Frontage Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Frontage Pharmacokinetic Research Service Product Portfolio
  102. 7.17.5 Frontage Recent Developments
  103. 7.18 Shanghai Model
  104. 7.18.1 Shanghai Model Company Information
  105. 7.18.2 Shanghai Model Business Overview
  106. 7.18.3 Shanghai Model Pharmacokinetic Research Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Shanghai Model Pharmacokinetic Research Service Product Portfolio
  108. 7.18.5 Shanghai Model Recent Developments
8 North America
  1. 8.1 North America Pharmacokinetic Research Service Revenue (2021-2032)
  2. 8.2 North America Pharmacokinetic Research Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmacokinetic Research Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmacokinetic Research Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmacokinetic Research Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmacokinetic Research Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmacokinetic Research Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmacokinetic Research Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmacokinetic Research Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmacokinetic Research Service Revenue by Country
  11. 8.6.1 North America Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmacokinetic Research Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmacokinetic Research Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmacokinetic Research Service Revenue (2021-2032)
  2. 9.2 Europe Pharmacokinetic Research Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmacokinetic Research Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmacokinetic Research Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmacokinetic Research Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmacokinetic Research Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmacokinetic Research Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmacokinetic Research Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmacokinetic Research Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmacokinetic Research Service Revenue by Country
  11. 9.6.1 Europe Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmacokinetic Research Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmacokinetic Research Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmacokinetic Research Service Revenue (2021-2032)
  2. 10.2 China Pharmacokinetic Research Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmacokinetic Research Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmacokinetic Research Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmacokinetic Research Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmacokinetic Research Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmacokinetic Research Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmacokinetic Research Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmacokinetic Research Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmacokinetic Research Service Revenue (2021-2032)
  2. 11.2 Asia Pharmacokinetic Research Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmacokinetic Research Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmacokinetic Research Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmacokinetic Research Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmacokinetic Research Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmacokinetic Research Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmacokinetic Research Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmacokinetic Research Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmacokinetic Research Service Revenue by Country
  11. 11.6.1 Asia Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmacokinetic Research Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmacokinetic Research Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmacokinetic Research Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmacokinetic Research Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmacokinetic Research Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmacokinetic Research Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmacokinetic Research Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmacokinetic Research Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmacokinetic Research Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmacokinetic Research Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmacokinetic Research Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmacokinetic Research Service Revenue by Country
  11. 12.6.1 SAMEA Pharmacokinetic Research Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmacokinetic Research Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmacokinetic Research Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst